Aging
Navigate
Submit an Article
Research Paper|Volume 14, Issue 15|pp. 6299–6315
Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
Back to articleFigure 10(10 of 10)
100%
Figure 10
Figure 10.(A) The mutational landscape of two immune subtypes (high risk and low risk) (B) The potential sensitive targeted drugs in high risk group and low risk group.